M. Ryberg

Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.

M. Ryberg, Dorte Nielsen, Torben Skovsgaard et al. · Journal of Clinical Oncology · 1998 · 285 citations

Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy

M. Ryberg, Dorte Nielsen, Kell Østerlind et al. · Annals of Oncology · 2001 · 54 citations · Full text

Prognostic Factors, Metastatic Breast Cancer, Oncology +7

Interleukin‐1 affects the function of cultured human thyroid cells

Åse Krogh Rasmussen, K. Bech, U. Feldt‐Rasmussen et al. · Allergy · 1988 · 42 citations

Phase II study of gemcitabine (2′,2′-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung c

Birthe Lund, M. Ryberg, Helén Anderson et al. · Annals of Oncology · 1994 · 30 citations · Full text

Medicine, Twice Weekly Schedule, Phase Ii Study +4

Malignant Disease After Radiation Treatment of Benign Gynaecological Disorders: A study of a cohort of metropathia patients

M. Ryberg, Marie Lundell, Bo Nilsson et al. · Acta Oncologica · 1990 · 21 citations · Full text

Radiation Effect, Malignant Tumours, Radiation Exposure +17